Pollack Ross A, Jones R Brad, Pertea Mihaela, Bruner Katherine M, Martin Alyssa R, Thomas Allison S, Capoferri Adam A, Beg Subul A, Huang Szu-Han, Karandish Sara, Hao Haiping, Halper-Stromberg Eitan, Yong Patrick C, Kovacs Colin, Benko Erika, Siliciano Robert F, Ho Ya-Chi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Microbiology, Immunology, and Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
Cell Host Microbe. 2017 Apr 12;21(4):494-506.e4. doi: 10.1016/j.chom.2017.03.008.
Despite antiretroviral therapy, HIV-1 persists in memory CD4 T cells, creating a barrier to cure. The majority of HIV-1 proviruses are defective and considered clinically irrelevant. Using cells from HIV-1-infected individuals and reconstructed patient-derived defective proviruses, we show that defective proviruses can be transcribed into RNAs that are spliced and translated. Proviruses with defective major splice donors (MSDs) can activate novel splice sites to produce HIV-1 transcripts, and cells with these proviruses can be recognized by HIV-1-specific cytotoxic T lymphocytes (CTLs). Further, cells with proviruses containing lethal mutations upstream of CTL epitopes can also be recognized by CTLs, potentially through aberrant translation. Thus, CTLs may change the landscape of HIV-1 proviruses by preferentially targeting cells with specific types of defective proviruses. Additionally, the expression of defective proviruses will need to be considered in the measurement of HIV-1 latency reversal.
尽管有抗逆转录病毒疗法,但HIV-1仍存在于记忆性CD4 T细胞中,这成为治愈的障碍。大多数HIV-1前病毒是有缺陷的,被认为与临床无关。利用来自HIV-1感染者的细胞和重建的患者来源的缺陷前病毒,我们发现缺陷前病毒可以转录成经剪接和翻译的RNA。具有缺陷主要剪接供体(MSD)的前病毒可以激活新的剪接位点以产生HIV-1转录本,含有这些前病毒的细胞可被HIV-1特异性细胞毒性T淋巴细胞(CTL)识别。此外,含有位于CTL表位上游致死性突变的前病毒的细胞也可能通过异常翻译被CTL识别。因此,CTL可能通过优先靶向具有特定类型缺陷前病毒的细胞来改变HIV-1前病毒的格局。此外,在测量HIV-1潜伏逆转时需要考虑缺陷前病毒的表达。